Navigation Links
Wyeth Announces Launch of Own Generic Version of PROTONIX
Date:1/29/2008

- Wyeth and Nycomed Continue Lawsuit to Enforce PROTONIX Patent -

MADISON, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Wyeth (NYSE: WYE) and its business partner, Nycomed, today announced the U.S. launch of Wyeth's own generic version of PROTONIX(R) tablets, in response to the at-risk launch of generic pantoprazole tablets in the U.S. by Teva Pharmaceuticals USA, Inc. on December 21, 2007. Wyeth's own generic version of PROTONIX will be distributed by Prasco starting today.

"Compound patents, like that infringed by Teva, represent the foundation of pharmaceutical innovation, a critical underpinning in bringing important new medicines to patients," says Bernard Poussot, President and Chief Executive Officer for Wyeth. "We believe the PROTONIX compound patent is strong and we will vigorously pursue our litigation against Teva and other infringing generics. Going forward, we will continue to seek an injunction against any infringement of this patent, as well as monetary damages, including lost profits, from Teva."

Wyeth and Altana Pharma AG (recently acquired by Nycomed) sued Teva and Sun Pharmaceuticals for patent infringement based on Teva's and Sun's filing of Abbreviated New Drug Applications (ANDAs) seeking U.S. Food and Drug Administration (FDA) approval to market generic versions of PROTONIX before the patent expires on July 19, 2010. Under the Hatch-Waxman Act, the filing of the lawsuit stayed final FDA approval of Teva's ANDA until August 2, 2007, and Sun's ANDA until September 8, 2007. On September 6, 2007, The United States District Court for the District of New Jersey denied Wyeth's and Nycomed's motion for preliminary injunction. The Court did not rule on the validity of the patent, but rather concluded that, ba
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Wyeth Declares Common and Preferred Stock Dividends
2. Wyeth and Teva Pharmaceuticals Extend the Standstill Period Relating to Tevas Launch of Generic Pantoprazole
3. Wyeth Receives Approvable Letter from FDA for Bazedoxifene for the Prevention of Postmenopausal Osteoporosis
4. Wyeth Sets Webcast and Conference Call for 2007 Fourth Quarter and Full Year Earnings
5. SmartOps Enterprise Inventory Optimization Software Licensed by Wyeth
6. Wyeth Receives Honors at the 2007 Scrip Awards
7. Wyeth Announces Executive Promotions
8. Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
9. Wyeth to Present at the Credit Suisse First Boston Healthcare Conference
10. Wyeth Consumer Healthcare Announces the Availability of Centrum Cardio and New Formula Centrum Products
11. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 Memorial Day weekend is ... Insurance is offering some tips to help promote safe ... there will be 383 traffic fatalities this Memorial Day weekend. ... National Highway Traffic Safety Association: , , ... vehicle is wearing a seatbelt, whether they’re driving or riding ...
(Date:5/22/2015)... PA (PRWEB) May 22, 2015 According to ... a hub for drug related death, totaling almost 2,500 confirmed ... as reported by state officials, totals 2,489 deaths stemming from ... work out, Pennsylvania loses seven people every day to fatal ... has been singled out as one of the most rife ...
(Date:5/22/2015)... A Phase 3 French study, which ... Clinical Oncology (ASCO)’s annual meeting at the end ... patients who received bevacizumab in addition to the ... Genentech, Inc.) is an antibody that blocks angiogenesis ... used to treat many other cancers, including lung ...
(Date:5/22/2015)... Steven Winter Associates (SWA) Vice President ... selected by Consulting-Specifying Engineer (CSE) magazine as a young ... in the May/June issue of the publication. , This ... 40 and younger who have, and continue to make ... in other areas of their professional and personal endeavors. ...
(Date:5/22/2015)... 22, 2015 Puritan Medical Products, ... the medical, diagnostic, environmental, and forensics industries celebrates ... products in the US. At a time when ... the US, Puritan remains committed to designing and ... Guilford, Maine facility. , Since 1919, Puritan has ...
Breaking Medicine News(10 mins):Health News:Amica Has 4 Road Safety Tips for Memorial Day Weekend 2Health News:Philadelphia Ranks Among the Tops Cities in Penn. for Drug Deaths 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2
... 14 (HealthDay News) -- In black Americans with type ... eye,s retina (retinal arteriolar narrowing) is associated with increased ... "Retinal arteriolar narrowing has long been described as one ... pressure] and cardiovascular disease," Dr. Monique Roy, of the ...
... A new study from the Regenstrief Institute and Indiana ... dementia are more likely to be living at home than ... that most individuals with dementia in the United States eventually ... Care for Older Adults With and Without Dementia" appears online ...
... , MONDAY, May 14 (HealthDay News) -- People ... significant improvement in the first six weeks, but may still ... a new study. Researchers analyzed data from 33 studies ... how treatment affects low-back pain. Their findings appear in the ...
... Using tiny solar-panel-like cells surgically placed underneath the retina, ... a system that may someday restore sight to people who ... diseases. This device a new type of retinal ... are equipped with a miniature camera and a pocket PC ...
... MI (May 9, 2012): Newly published results from a ... under development by Hygieia, Inc., demonstrate DIGS, potential to ... 2 or type 1 diabetes. DIGS automatically adjusted insulin ... Over the 12-week intervention period of the study, investigators ...
... May 11 (HealthDay News) -- A type of therapy that ... children but not severely obese teens, new research suggests. ... male) aged 6 to 16, who began "behavioral treatment" for ... method for assessing weight data that took into account the ...
Cached Medicine News:Health News:Individuals with dementia more likely to die at home than in nursing homes 2Health News:Back Pain Therapy Often Yields Early Benefits: Study 2Health News:New type of retinal prosthesis could better restore sight to blind, Stanford study says 2Health News:New type of retinal prosthesis could better restore sight to blind, Stanford study says 3Health News:New type of retinal prosthesis could better restore sight to blind, Stanford study says 4Health News:Automated insulin dosage titration system demonstrates positive clinical study results 2Health News:Sooner Is Better for Controlling Obese Kids' Weight: Study 2
(Date:5/22/2015)... -- According to a new market research ... Services), by Test Type (Indirect, Enzyme-based, Reactive Oxygen Species ... Users - Global Forecast to 2020", published by MarketsandMarkets, the ... $736.85 Million by 2020 from $452.36 Million in 2015, ... Browse 71 market data Tables and 90 Figures spread ...
(Date:5/22/2015)... DUBLIN , May 22, 2015 Research ... announced the addition of the "Latest Regulations ... report to their offering. This ... officially issued a guidance on international multi-center clinical ... , which has begun to be implemented on ...
(Date:5/22/2015)... -- Richmond Pharmacology is a university ... worldwide reputation for excellence in clinical trials. It ... reviewed medical journals. Its officers are engaged with ... about rules for transparency and publication of clinical ... Clinical research is conducted worldwide, therefore ...
Breaking Medicine Technology:Oxidative Stress Assays Market Worth $736.85 Million by 2020 2Oxidative Stress Assays Market Worth $736.85 Million by 2020 3Oxidative Stress Assays Market Worth $736.85 Million by 2020 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... Md. , May 26 The U.S. Food and Drug Administration ... liver injury in patients taking the weight-loss medication orlistat, marketed as Xenical and ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ... The FDA has approved a ...
... ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA ), today announced it will present at ... on June 9, 2010 , in New York, NY . ... provide an update on the Company,s marketed products and clinical programs. , ... The presentation will be webcast. To access ...
Cached Medicine Technology:FDA: Rare Cases of Liver Injury Reported With Use of Xenical, Alli 2FDA: Rare Cases of Liver Injury Reported With Use of Xenical, Alli 3ISTA Pharmaceuticals to Present at the Jefferies 2010 Global Life Sciences Conference 2
... Post Operative Pin® Knee Brace (DxHDDLP) has a ... drop lock lever and laminate liner. The precision ... brace from migrating on the leg during ambulation. ... that controls flexion and extension in 5° increments ...
... Neuroprene™ soft supports are a convenient, ... proprioceptive taping for common orthopedic conditions/instabilities. ... provide specific compression and lateral to ... (proprioceptors) in the skin and soft ...
... The Drytex Adjustable Patella Donut ... a unique nylon core and polyester ... airflow. A trimable full-circumference donut provides ... who have neoprene based allergies or ...
... for total knees, meniscus repairs, regenerative chondroplasty, ... TROM gives easy-to-use range of motion control ... Rehab TROM can be used as a ... purchased separately be used with the TROM ...
Medicine Products: